SMP

Axonius Announces $200 Million Series E Extension Amid Explosive Growth

Retrieved on: 
Tuesday, March 5, 2024

NEW YORK, March 05, 2024 (GLOBE NEWSWIRE) -- Axonius, the leader in cybersecurity asset management and SaaS management, today announced it has secured $200 million in a Series E extension funding round led by Accel and Lightspeed Venture Partners. Existing investor Stripes also participated. This new round of funding is intended to accelerate innovation and scale across the globe as demand for the Axonius Platform continues to grow. The company crossed $100 million in annual recurring revenue in 2023 as it continues to expand its customer base, which includes more than a dozen of the Fortune 500 and global organizations such as Schneider Electric, News Corp, and Anheuser-Busch InBev. The company also supports four of the five major U.S. Department of Defense service agencies.

Key Points: 
  • NEW YORK, March 05, 2024 (GLOBE NEWSWIRE) -- Axonius, the leader in cybersecurity asset management and SaaS management , today announced it has secured $200 million in a Series E extension funding round led by Accel and Lightspeed Venture Partners.
  • This new round of funding is intended to accelerate innovation and scale across the globe as demand for the Axonius Platform continues to grow.
  • "Axonius has gone from zero revenue to exceeding $100 million in ARR in just 4.5 years, making us one of the fastest growing cybersecurity companies,” said Dean Sysman, CEO and Co-founder at Axonius.
  • The more integrations, the more information Axonius can surface about security gaps, risk, misconfigurations, cost inefficiencies, and more.

European Commission announces new competitions for 2025 - European Capital and Green Pioneer of Smart Tourism

Retrieved on: 
Thursday, March 7, 2024

BRUSSELS, March 7, 2024 /PRNewswire/ -- Today, the European Commission launches the 2025 edition of the European Capital of Smart Tourism and the European Green Pioneer of Smart Tourism competitions.

Key Points: 
  • BRUSSELS, March 7, 2024 /PRNewswire/ -- Today, the European Commission launches the 2025 edition of the European Capital of Smart Tourism and the European Green Pioneer of Smart Tourism competitions.
  • Tourism destinations across Europe are invited to submit their innovative practices of smart and sustainable tourism to become leading examples in European tourism.
  • With these competitions, the European Commission promotes and awards the future of smart and sustainable tourism in Europe.
  • The European Jury will select two winners, the 'European Capital of Smart Tourism 2025' and the 'European Green Pioneer of Smart Tourism 2025', which will be announced in November 2024.

European Commission announces new competitions for 2025 - European Capital and Green Pioneer of Smart Tourism

Retrieved on: 
Thursday, March 7, 2024

BRUSSELS, March 7, 2024 /PRNewswire/ -- Today, the European Commission launches the 2025 edition of the European Capital of Smart Tourism and the European Green Pioneer of Smart Tourism competitions.

Key Points: 
  • BRUSSELS, March 7, 2024 /PRNewswire/ -- Today, the European Commission launches the 2025 edition of the European Capital of Smart Tourism and the European Green Pioneer of Smart Tourism competitions.
  • Tourism destinations across Europe are invited to submit their innovative practices of smart and sustainable tourism to become leading examples in European tourism.
  • With these competitions, the European Commission promotes and awards the future of smart and sustainable tourism in Europe.
  • The European Jury will select two winners, the 'European Capital of Smart Tourism 2025' and the 'European Green Pioneer of Smart Tourism 2025', which will be announced in November 2024.

ARKEMA will be attending this year's JEC edition with A unique portfolio of materials for Composites STAND 5T40 - HALL 5

Retrieved on: 
Thursday, February 29, 2024

PI films are used in various industries, including smart devices, electric vehicles, semiconductors, displays, aerospace, and industrial applications.

Key Points: 
  • PI films are used in various industries, including smart devices, electric vehicles, semiconductors, displays, aerospace, and industrial applications.
  • UNLEASHING THE FUTURE WITH ARKEMA'S UDX® TAPES - Arkema is proud to present a range of semi-finished composite products under the UDX® brand.
  • Building on its unique set of expertise in materials science, Arkema offers a portfolio of first-class technologies to address ever-growing demand for new and sustainable materials.
  • The Group reported sales of around € 11.5 billion in 2022, and operates in some 55 countries with 21,100 employees worldwide.

ARKEMA will be attending this year's JEC edition with A unique portfolio of materials for Composites STAND 5T40 - HALL 5

Retrieved on: 
Thursday, February 29, 2024

PI films are used in various industries, including smart devices, electric vehicles, semiconductors, displays, aerospace, and industrial applications.

Key Points: 
  • PI films are used in various industries, including smart devices, electric vehicles, semiconductors, displays, aerospace, and industrial applications.
  • UNLEASHING THE FUTURE WITH ARKEMA'S UDX® TAPES - Arkema is proud to present a range of semi-finished composite products under the UDX® brand.
  • Building on its unique set of expertise in materials science, Arkema offers a portfolio of first-class technologies to address ever-growing demand for new and sustainable materials.
  • The Group reported sales of around € 11.5 billion in 2022, and operates in some 55 countries with 21,100 employees worldwide.

Scam Alert: Scammers are billing for unneeded urinary catheters

Retrieved on: 
Tuesday, February 27, 2024

WASHINGTON, Feb. 27, 2024 /PRNewswire/ -- Medicare beneficiaries across the country are finding charges worth thousands of dollars on their Medicare statements related to urinary catheters that were not needed or received.

Key Points: 
  • WASHINGTON, Feb. 27, 2024 /PRNewswire/ -- Medicare beneficiaries across the country are finding charges worth thousands of dollars on their Medicare statements related to urinary catheters that were not needed or received.
  • "Scammers are taking advantage of the Medicare program and billing for unnecessary products, which is hurting the program.
  • This is also putting Medicare beneficiaries' Medicare card numbers at risk and compromising their medical identities," said Nicole Liebau, director of the Senior Medicare Patrol (SMP) Resource Center.
  • To learn how to read Medicare statements or get help with a compromised Medicare number, contact your local SMP.

Standard Motor Products, Inc. Announces Fourth Quarter and Year End 2023 Earnings Conference Call

Retrieved on: 
Tuesday, February 20, 2024

Standard Motor Products, Inc. will hold a conference call at 11:00 AM, Eastern Time, on Thursday, February 22, 2024.

Key Points: 
  • Standard Motor Products, Inc. will hold a conference call at 11:00 AM, Eastern Time, on Thursday, February 22, 2024.
  • This call will be webcast and can be accessed on the Investor Relations page of our website at www.smpcorp.com and clicking on the SMP Q4'23 Earnings Call Earnings Webcast link.
  • Investors may also listen to the call by dialing 800-245-3047 (domestic) or 203-518-9765 (international).
  • For those choosing to listen to the replay by webcast, the link should be active on our website within 24 hours after the call.

Pancreatic Cancer Treatments Poised for Major Advances in 2024

Retrieved on: 
Wednesday, February 7, 2024

VANCOUVER, BC, Feb. 7, 2024 /PRNewswire/ -- USA News Group  -  One of the more worrying storylines of 2023 was the rising incidence of early-onset pancreatic cancer. As well, the deadly disease showed pancreatic cancer rates rising faster among women, causing increased alarm amongst doctors. Thankfully, 2023 also gave a lot of hope in terms of new treatments for the market that could reach US$36 billion by 2036, such as a potential mRNA vaccine, and other developments from biotech companies to lead into 2024, like Oncolytics Biotech Inc. (NASDAQ:ONCY) (TSX:ONC), Incyte Corporation (NASDAQ:INCY), Tango Therapeutics, Inc. (NASDAQ:TNGX), RayzeBio, Inc. (NASDAQ:RYZB) and its buyer Bristol-Myers Squibb Company (NYSE:BMY).

Key Points: 
  • VANCOUVER, BC, Feb. 7, 2024 /PRNewswire/ -- USA News Group -  One of the more worrying storylines of 2023 was the rising incidence of early-onset pancreatic cancer .
  • As well, the deadly disease showed pancreatic cancer rates rising faster among women , causing increased alarm amongst doctors.
  • After closing out 2022 with another fast track designation , Oncolytics Biotech Inc. (NASDAQ:ONCY) (TSX:ONC) and its flagship asset pelareorep continues to make strides in the battle against pancreatic cancer.
  • The results were enough to garner the support of the Pancreatic Cancer Action Network (PanCAN), who selected pelareorep to receive the US$5 million Therapeutic Accelerator Award .

Pancreatic Cancer Treatments Poised for Major Advances in 2024

Retrieved on: 
Wednesday, February 7, 2024

VANCOUVER, BC, Feb. 7, 2024 /PRNewswire/ -- USA News Group  -  One of the more worrying storylines of 2023 was the rising incidence of early-onset pancreatic cancer. As well, the deadly disease showed pancreatic cancer rates rising faster among women, causing increased alarm amongst doctors. Thankfully, 2023 also gave a lot of hope in terms of new treatments for the market that could reach US$36 billion by 2036, such as a potential mRNA vaccine, and other developments from biotech companies to lead into 2024, like Oncolytics Biotech Inc. (NASDAQ:ONCY) (TSX:ONC), Incyte Corporation (NASDAQ:INCY), Tango Therapeutics, Inc. (NASDAQ:TNGX), RayzeBio, Inc. (NASDAQ:RYZB) and its buyer Bristol-Myers Squibb Company (NYSE:BMY).

Key Points: 
  • VANCOUVER, BC, Feb. 7, 2024 /PRNewswire/ -- USA News Group -  One of the more worrying storylines of 2023 was the rising incidence of early-onset pancreatic cancer .
  • As well, the deadly disease showed pancreatic cancer rates rising faster among women , causing increased alarm amongst doctors.
  • After closing out 2022 with another fast track designation , Oncolytics Biotech Inc. (NASDAQ:ONCY) (TSX:ONC) and its flagship asset pelareorep continues to make strides in the battle against pancreatic cancer.
  • The results were enough to garner the support of the Pancreatic Cancer Action Network (PanCAN), who selected pelareorep to receive the US$5 million Therapeutic Accelerator Award .

Standard Motor Products' Emission Control Program Expands

Retrieved on: 
Wednesday, February 7, 2024

NEW YORK, Feb. 7, 2024 /PRNewswire/ -- Standard Motor Products, Inc. (SMP) is dedicated to expanding its comprehensive Emission Control program. Standard's Emission Control program includes evaporative emission control (EVAP), exhaust gas recirculation (EGR), and positive crankcase ventilation emission control systems. With more than 3,500 part numbers, Standard® offers the most complete program in the industry, with everything needed for a complete repair.

Key Points: 
  • Standard's Emission Control program features more than 3,500 parts, including EVAP, EGR, and positive crankcase ventilation products
    SMP manufactures emission control components in its own North American facilities located in South Carolina, Kansas, and Mexico
    Standard® is committed to expanding its comprehensive emission control program, with new products continually released
    NEW YORK, Feb. 7, 2024 /PRNewswire/ -- Standard Motor Products, Inc. (SMP) is dedicated to expanding its comprehensive Emission Control program.
  • Standard's Emission Control program includes evaporative emission control (EVAP), exhaust gas recirculation (EGR), and positive crankcase ventilation emission control systems.
  • Standard® emission components are manufactured in three of SMP's North American facilities in Greenville, South Carolina, Independence, Kansas, and Reynosa, Mexico.
  • All new Standard® Emission Control applications are listed in the catalog found at StandardBrand.com and in electronic catalog providers.